Alto Neuroscience, Inc.
ANRO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001999480
No open-market purchases or sales by Alto Neuroscience, Inc. insiders were filed in the last 90 days; 114 institutions reported holding it in 13F filings for Q2 2026, worth $777.6M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +5 vs. previous quarter
- 114
- 13F valueReported value at the end of Q2 2026
- $777.6M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ANRO, Q2 2026
No superinvestor reported holding ANRO at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Alto Neuroscience, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 11, 2024 (view filing) | Jul 9-10 | 2 days | Savitz AdamCHIEF MEDICAL OFFICER | PPurchase | +15.0K | $12.72 | +$190.8K | +60.4%39.9K after | 3 lots |
| Apr 1, 2024 (view filing) | Mar 28 | 4 days | Smith Nicholas ConradCHIEF FINANCIAL OFFICER | PPurchase | +6.15K | $16.36 | +$100.6K | +29.7%26.9K after | 2 lots |
| Feb 8, 2024 (view filing)4:32 PM ET | Feb 6 | 2 days | Alpha Wave Global, LP and 3 others10% Owner | PPurchase | +600.0K | $16.00 | +$9.60M | +19.3%3.71M after | |
| Feb 7, 2024 (view filing) | Feb 6 | 1 day | Smith Nicholas ConradCHIEF FINANCIAL OFFICER | PPurchase | +1.56K | $16.00 | +$25.0K | New position1.56K after | |
| Feb 7, 2024 (view filing) | Feb 6 | 1 day | Savitz AdamCHIEF MEDICAL OFFICER | PPurchase | +17.0K | $16.00 | +$272.0K | +216.5%24.9K after | |
| Feb 7, 2024 (view filing) | Feb 6 | 1 day | Etkin AmitPRESIDENT AND CEO | PPurchase | +3.13K | $16.00 | +$50.0K | +0.3%1.21M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Alto Neuroscience, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Falcon Edge Capital, LP | 3,707,757 | $97.8M | 1.57% | 00.0% | Unchanged |
| Commodore Capital LP | 2,723,196 | $71.9M | 4.28% | 00.0% | Unchanged |
| BlackRock, Inc. | 2,121,009 | $56.0M | 0.00% | +1,454,821+218.4% | Added |
| Perceptive Advisors LLC | 1,609,893 | $42.5M | 0.66% | −400,000−19.9% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,600,000 | $42.2M | 0.06% | +1,215,000+315.6% | Added |
| Vanguard Capital Management LLC | 1,389,477 | $36.7M | 0.00% | +182,452+15.1% | Added |
| Spruce Street Capital LP | 1,353,047 | $35.7M | 7.01% | +27,837+2.1% | Added |
| Vivo Capital, LLC | 1,208,858 | $31.9M | 2.91% | +173,307+16.7% | Added |
| Franklin Resources Inc | 1,013,307 | $26.7M | 0.01% | −88,567−8.0% | Reduced |
| Armistice Capital, LLC | 864,000 | $22.8M | 0.63% | −48,000−5.3% | Reduced |